Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer

Completed · Phase 3

Conditions studied: Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Etanercept is a substance that is being studied as a treatment for cachexia (weight loss) and anorexia (lack of appetite) in patients who have cancer. It is not yet known whether etanercept is effective in improving cancer-related cachexia and anorexia. PURPOSE: Randomized phase III trial to determine the effectiveness of etanercept in treating cancer-related cachexia and anorexia in patients who have advanced cancer.

Key facts

Study ID
NCT00046904
Run by
Mayo Clinic
Starts
2003-05-01
Last updated by the study team
2011-05-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.